Advertisement
open access
Medical Conferences
Conference Reports
Conference Proceedings
Disease Areas
Medical News
Multimedia
Podcast Channel
Videos
Webinar
About
2024 Medicom Conference Planning
Conference Proceedings
Home
>
Rheumatology
>
ACR 2019
ACR 2019
American College of Rheumatology
8–13 November 2019 Atlanta, Georgia, USA
Read the full Report (e-book)
Table of Contents
Colophon
Table of Contents
Featured articles
Introduction to the Conference Report of the ACR
Editor Biography
Editor
Prof. Dennis McGonagle, University of Leeds, England
Late-Breaking Abstracts
Lowest risk of infection after therapy with an IL-12/IL-23 blocker
Presented By
Dr Yinzhu Jin, Brigham and Women´s Hospital and Harvard Medical School, Boston, USA
Calcium pyrophosphate deposition disease: an independent risk factor for cardiovascular complications
Presented By
Dr Maaman Bashir, Medical College of Wisconsin, USA
Proteome abnormalities improve prediction of RA development
Presented By
Dr Liam O´Neil, University of Manitoba, Canada
RA patients in remission benefit from continued therapy with conventional DMARDs
Presented By
Dr Siri Lillegraven, Diakonhjemmet Hospital,Norway
Selective IL-23 blocker shows remarkable efficacy in patients with psoriatic arthritis
Presented By
Prof. Atul Deodhar, Oregon Health & Science University, USA
Corticosteroid therapy in GCA: higher platelets – lower relapse rate
Presented By
Dr Samuel Deshayes, Hospital Center University Of Caen Normandie, France
Spotlight on Rheumatoid Arthritis
Filgotinib promising in RA patients naïve to methotrexate
Presented By
Prof. Rene Westhovens, University of Leuven, Belgium
Sustained efficacy of monotherapy with upadacitinib after 48 weeks
Presented By
Prof. Joseph Smolen, Medical University of Vienna, Austria
Biologics show similar activity in patients with elderly-onset RA
Presented By
Dr Sadao Jinno, Kobe University School of Medicine, Japan
Tocilizumab outperforms rituximab in RA patients with low level of synovial B cell infiltration
Presented By
Prof. Costantino Pitzalis, Barts and The London School of Medicine and Dentistry, UK
Treatment decisions should not be guided by ultrasound findings
Presented By
Dr Espen Haavardsholm, Diakonhjemmet Hospital, Oslo, Norway
Cancer treatment with checkpoint inhibitors in RA patients?
Presented By
Dr Sabina Sandigursky, New York University Langone Medical Center, USA
What is Hot in Systemic Lupus Erythematosus
Anifrolumab succeeds in second phase 3 trial in SLE
Presented By
Prof. Eric Morand, Prof. Richard Furie
Depression closely related to fatigue in SLE patients
Presented By
Christina Düsing, Universitätsklinikum Düsseldorf, Germany
Spondyloarthritis – The Beat Goes On
Psoriasis onset determines sequence of symptoms
Presented By
Prof. Umut Kalyoncu, Hacettepe University, Turkey
Higher psychiatric comorbidity in women with PsA
Presented By
Prof. Mehmet Duruöz, Marmara University Hospital, Turkey
JAK1 inhibition shows remarkable efficacy in AS
Presented By
Prof. Désirée van der Heijde, Leiden University Medical Center, the Netherlands
CARDAS study shows increased prevalence of cardiac valvular disorders in AS patients
Presented By
Mr Milad Baniaamam, Amsterdam University Medical Center, the Netherlands
Osteoarthritis – State-of-the-Art
Hand OA: low-dose corticosteroids improve symptoms
Presented By
Dr Féline Kroon, Prof. Christian Roux
Opioids: no quality of life benefits for OA patients
Presented By
Dr Raveendhara Bannuru, Tufts Medical Center, USA
Walking speed is a predictor of mortality in patients with knee OA
Presented By
Dr Hiral Master, University of Delaware,, USA
Reproductive Issues in Rheumatic Disease
Few serious infections in offspring with exposure to non-TNFi biologics or tofacitinib
Presented By
Dr Evelyne Vinet, McGill University, Montreal, Canada
Prevention of congenital heart block may be possible with hydroxychloroquine
Presented By
Prof. Peter Izmirly, New York University School of Medicine, USA
TNFi for RA during pregnancy – to stop or not to stop?
Presented By
Dr Isabell Haase, Heinrich-Heine University Düsseldorf, Germany
Vasculitis – Novel Treatment Modalities
Rituximab maintenance superior to azathioprine in ANCA-associated vasculitis
Presented By
Dr Rona Smith, University of Cambridge, UK
Prolonged remission after stop of tocilizumab for patients with giant cell arteritis
Presented By
Prof. John H. Stone, Harvard Medical School, Boston, USA
Best of the Posters
Antifibrotic therapy slows disease progression independent of corticosteroid use
Presented By
Dr Madelon Vonk, Radboud University, the Netherlands
Fibromyalgia patients often experienced abuse in childhood
Presented By
Dr Carmen Gota, Cleveland Clinic, Ohio, USA